Medicine reading guide
Dupilumab (Dupixent)
Dupixent injection for adult moderate-to-severe atopic dermatitis. Educational draft. Independent clinical review pending. Not personal medical advice.
How it works
In atopic dermatitis, signals from the immune system can contribute to skin inflammation. Dupilumab attaches to a shared part of the receptors used by two of those signals, called IL-4 and IL-13. This reduces their signaling and can improve eczema symptoms such as itch.
Dupixent prescribing information · §§12.1 and 14.1
Audience explanation sources
Editorial source review completed November 11, 2026. Independent clinical review pending. Audience versions explain the same scoped medicine; they are not separate treatment plans.
Educational draft. Independent clinical review pending.
Written explanation
Adults using subcutaneous Dupixent for moderate-to-severe atopic dermatitis inadequately controlled by prescription topical treatments, or when those treatments are inadvisable. Excludes other indications, children and device-specific training.
Existing authored material. Source-check record: 2026-10-12. Independent clinical review pending.
Target: dupilumab binds IL-4 receptor alpha, a shared part of two immune-signaling receptor systems.
Signal reduced: this inhibits IL-4 and IL-13 signaling involved in atopic inflammation. The full clinical mechanism is not definitively established.
What is it for?
Moderate-to-severe atopic dermatitis when prescription topical therapy is inadequate or inadvisable.
How does it work?
Two immune-system signals, IL-4 and IL-13, help drive the inflammation in eczema. Dupilumab attaches to a shared part of the receivers for these signals. This reduces the signals getting through and can help calm skin inflammation.
Can topical treatment continue?
The label permits use with or without topical corticosteroids; follow your dermatologist's plan.
Can I inject it myself?
Only after training. Follow the instructions for your prescribed pen or syringe.
What side effects might occur?
Injection-site reactions, eye inflammation and oral herpes were reported in atopic-dermatitis trials.
What if my eyes become irritated?
Report new or worsening eye pain, redness, swelling or vision changes promptly.
When should I seek emergency help?
Stop use and seek emergency help for facial/throat swelling, breathing difficulty or fainting.
What about vaccines and other medicines?
Check medicines and vaccines with your clinician. Live vaccines should be avoided during treatment.
Why ask about worm infections?
Parasitic worms are also called helminths. An existing worm infection should be treated before starting dupilumab. Tell your clinician if you think you have an infection during treatment.
Can I abruptly stop other steroids?
No. Any reduction of oral, inhaled or topical corticosteroids needs clinical supervision.
What about pregnancy or breastfeeding?
Discuss pregnancy plans or breastfeeding with your clinician.